A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: Towards a matrix-based therapy?

European Cells and Materials

Volumn 30, Issue , 2015, Pages 51-68

  Chevalier, F ^a,c   Arnaud, D ^b   Henault, E ^a   Guillevic, O ^c   Sineriz F ^d   Ponsen, A C ^c   Papy Garcia, D ^a   Barritault, D ^d   Letourneur, D ^b   Uzan, G ^c   Meddahi Pelle A ^b   Hlawaty, H ^b   Albanese, Patricia ^a  

^a Université Paris Est ^*  (France)

^b Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d OTR3   (France)

Author keywords

Angiogenesis; Glycosaminoglycan; Ischaemia; Matrix therapy; Skeletal muscle; Tissue remodelling

Indexed keywords

CHONDROITIN SULFATE; DISACCHARIDE; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN BINDING PROTEIN; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAF32 CELL; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CARBOHYDRATE SYNTHESIS; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTENSOR DIGITORUM LONGUS MUSCLE; GENE EXPRESSION ASSAY; HISTOPATHOLOGY; HOMEOSTASIS; IN VIVO STUDY; MALE; MITOGENESIS; MUSCLE ISCHEMIA; MUSCLE REGENERATION; NONHUMAN; PROTEIN EXPRESSION; RAT; STRUCTURE ANALYSIS; SULFATION; ANIMAL; CELL CULTURE; DISEASE COURSE; GENE EXPRESSION; ISCHEMIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; WISTAR RAT;

ANIMALS; CELLS, CULTURED; CHONDROITIN SULFATES; DISEASE PROGRESSION; GENE EXPRESSION; GLYCOSAMINOGLYCANS; ISCHEMIA; MALE; MUSCLE, SKELETAL; RATS, WISTAR; REGENERATION;

EID: 84940941727     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v030a05     Document Type: Article

References (72)

1. Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK (2005) Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 563: 507-516.
2. Albanese P, Caruelle D, Frescaline G, Delbe J, Petit-Cocault L, Huet E, Charnaux N, Uzan G, Papy-Garcia D, Courty J (2009) Glycosaminoglycan mimetics-induced mobilization of haematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights. Exp Hematol 37: 1072-1083.
3. Allen RE, Boxhorn LK (1989) Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 138: 311-315.
4. Barallobre-Barreiro J, Didangelos A, Schoendube FA, Drozdov I, Yin X, Fernandez-Caggiano M, Willeit P, Puntmann VO, Aldama-Lopez G, Shah AM, Domenech N, Mayr M (2012) Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischaemia/reperfusion injury. Circulation 125: 789-802.
5. Barbier-Chassefiere V, Garcia-Filipe S, Yue XL, Kerros ME, Petit E, Kern P, Saffar JL, Papy-Garcia D, Caruelle JP, Barritault D (2009) Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A 90: 641-647.
6. Barbosa I, Garcia S, Barbier-Chassefiere V, Caruelle JP, Martelly I, Papy-Garcia D (2003) Improved and simple micro assay for sulphated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13: 647-653.
7. Berger JS, Hiatt WR (2012) Medical therapy in peripheral artery disease. Circulation 126: 491-500.
8. Bink RJ, Habuchi H, Lele Z, Dolk E, Joore J. Rauch, GJ, Geisler R, Wilson SW, den Hertog J, Kimata K, Zivkovic D (2003) Heparan sulphate 6-O-sulfotransferase is essential for muscle development in zebrafish. J Biol Chem 278: 31118-31127.
9. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC (1998) Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384.
10. Carlson BM, Gutmann E (1975) Regneration in free grafts of normal and denervated muscles in the rat: morphology and histochemistry. Anat Rec 183: 47-62.
11. Carter NM, Ali S, Kirby JA (2003) Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate. J Cell Sci 116: 3591-3600.
12. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E (2004) Heparan sulphate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci 117: 73-84.
13. Chen CH, Poucher SM, Lu J, Henry PD (2004) Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2: 33-43.
14. Chevalier F, Lavergne M, Negroni E, Ferratge S, Carpentier G, Gilbert-Sirieix M, Sineriz F, Uzan G, Albanese P (2014) Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies. Stem Cell Res 12: 703-715.
15. Clarke MS, Khakee R, McNeil PL (1993) Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibres of normal and dystrophic muscle. J Cell Sci 106: 121-133.
16. Cornelison DD, Filla MS, Stanley HM, Rapraeger AC, Olwin BB (2001) Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 239: 79-94.
17. Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM (1994) A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med 22: 702-710.
18. Deng B, Wehling-Henricks M, Villalta SA, Wang Y, Tidball JG (2012) IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 189: 3669-3680.
19. Desgranges P, Barbaud C, Caruelle JP, Barritault D, Gautron J (1999) A substituted dextran enhances muscle fiber survival and regeneration in ischaemic and denervated rat EDL muscle. FASEB J 13: 761-766.
20. Desouza CV, Hamel FG, Bidasee K, O’Connell K (2011) Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60: 1286-1294.
21. Drobnik J, Szczepanowska A, Dabrowski R (2004) Temporary augmentation of glycosaminoglycans content in the heart after left coronary artery ligation. Pathophysiology 11: 35-39.
22. Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E (2006) Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 25: 332-341.
23. Friedl A, Chang Z, Tierney A, Rapraeger AC (1997) Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulphate: comparison of normal and abnormal human tissues. Am J Pathol 150: 1443-1455.
24. Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72: 455-482.
25. Garcia-Filipe S, Barbier-Chassefiere V, Alexakis C, Huet E, Ledoux D, Kerros ME, Petit E, Barritault D, Caruelle JP, Kern P (2007) RGTA OTR4120, a heparan sulphate mimetic, is a possible long-term active agent to heal burned skin. J Biomed Mater Res A 80: 75-84.
26. Goussetis E, Manginas A, Koutelou M, Peristeri I, Theodosaki M, Kollaros N, Leontiadis E, Theodorakos A, Paterakis G, Karatasakis G, Cokkinos DV, Graphakos S (2006) Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischaemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells 24: 2279-2283.
27. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE (2005) Regulation of protein function by glycosaminoglycans – as exemplified by chemokines. Annu Rev Biochem 74: 385-410.
28. Huynh MB, Morin C, Carpentier G, Garcia-Filipe S, Talhas-Perret S, Barbier-Chassefiere V, van Kuppevelt TH, Martelly I, Albanese P, Papy-Garcia D (2012a) Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulphate-altered sulphation. J Biol Chem 287: 11363-11373.
29. Huynh MB, Villares J, Diaz JE, Christiaans S, Carpentier G, Ouidja MO, Sissoeff L, Raisman-Vozari R, Papy-Garcia D (2012b) Glycosaminoglycans from aged human hippocampus have altered capacities to regulate trophic factors activities but not Abeta42 peptide toxicity. Neurobiol Aging 33: 1005 e11-22.
30. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085-25092.
31. Knall C, Worthen GS, Johnson GL (1997) Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 94: 3052-3057.
32. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801.
33. Kochtebane N, Passefort S, Choqueux C, Ainoun F, Achour L, Michel JB, Back M, Jacob MP (2013) Release of leukotriene B4, transforming growth factor-beta1 and microparticles in relation to aortic valve calcification. J Heart Valve Dis 22: 782-788.
34. Lallam-Laroye C, Escartin Q, Zlowodzki AS, Barritault D, Caruelle JP, Baroukh B, Saffar JL, Colombier ML (2006) Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic. J Biomed Mater Res A 79: 675-683.
35. Langsdorf A, Do AT, Kusche-Gullberg M, Emerson CP, Jr., Ai X (2007) Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev Biol 311: 464-477.
36. Li J, Shworak NW, Simons M (2002) Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulphate FGF2-binding sites. J Cell Sci 115: 1951-1959.
37. Lortat-Jacob H (2009) The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr Opin Struct Biol 19: 543-548.
38. Luyt CE, Meddahi-Pelle A, Ho-Tin-Noe B, Colliec-Jouault S, Guezennec J, Louedec L, Prats H, Jacob MP, Osborne-Pellegrin M, Letourneur D, Michel JB (2003) Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischaemia. J Pharmacol Exp Ther 305: 24-30.
39. Mangoni M, Yue X, Morin C, Violot D, Frascogna V, Tao Y, Opolon P, Castaing M, Auperin A, Biti G, Barritault D, Vozenin-Brotons MC, Deutsch E, Bourhis, J (2009) Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. Int J Radiat Oncol Biol Phys 74: 1242-1250.
40. Marastoni S, Ligresti G, Lorenzon E, Colombatti A, Mongiat M (2008) Extracellular matrix: a matter of life and death. Connect Tissue Res 49: 203-206.
41. Matsui Y, Ikesue M, Danzaki K, Morimoto J, Sato M, Tanaka S, Kojima T, Tsutsui H, Uede T (2011) Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 108: 1328-1339.
42. Meddahi A, Lemdjabar H, Caruelle JP, Barritault D, Hornebeck W (1995) Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation. Biochimie 77: 703-706.
43. Meddahi A, Alexakis C, Papy D, Caruelle JP, Barritault D (2002) Heparin-like polymer improved healing of gastric and colic ulceration. J Biomed Mater Res 60: 497-501.
44. Melo F, Carey DJ, Brandan E (1996) Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J Cell Biochem 62: 227-239.
45. Mikami T, Koyama S, Yabuta Y, Kitagawa H (2012) Chondroitin sulphate is a crucial determinant for skeletal muscle development/regeneration and improvement of muscular dystrophies. J Biol Chem 287: 38531-38542.
46. Najjam S, Gibbs RV, Gordon MY, Rider CC (1997) The binding of interleukin 2 to heparin revealed by a novel ELISA method. Biochem Soc Trans 25: 3S.
47. Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V (2006) HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res 66: 6025-6032.
48. Negroni E, Henault E, Chevalier F, Gilbert-Sirieix M, Van Kuppevelt TH, Papy-Garcia D, Uzan G, Albanese P (2014) Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulphate/dermatan sulphate. J Neuropathol Exp Neurol 73: 789-97.
49. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12: 240-247.
50. Osses N, Brandan E (2002) ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol 282: C383-394.
51. Papy-Garcia D, Barbier-Chassefiere V, Rouet V, Kerros ME, Klochendler C, Tournaire MC, Barritault D, Caruelle JP, Petit E (2005) Nondegradative sulphation of polysaccharides. Synthesis and structure characterization of biologically active heparan sulphate mimetics. Macromolecules 38: 4647-4654.
52. Rabbany SY, Heissig B, Hattori K, Rafii S (2003) Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 9: 109-117.
53. Raval Z, Losordo DW (2013) Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 112: 1288-1302.
54. Rouet V, Hamma-Kourbali Y, Petit E, Panagopoulou P, Katsoris P, Barritault D, Caruelle JP, Courty J (2005) A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis. J Biol Chem 280: 32792-32800.
55. Rouet V, Meddahi-Pelle A, Miao HQ, Vlodavsky I, Caruelle JP, Barritault D (2006) Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro. J Biomed Mater Res A 78: 792-797.
56. Schumann K, Lammermann T, Bruckner M, Legler DF, Polleux J, Spatz JP, Schuler G, Forster R, Lutz MB, Sorokin L, Sixt M (2010) Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32: 703-713.
57. Sobieszczyk P, Eisenhauer A (2013) Management of patients after endovascular interventions for peripheral artery disease. Circulation 128: 749-757.
58. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85: 699-715.
59. Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH (2004) Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110: II219-224.
60. Terrovitis J, Lautamaki R, Bonios M, Fox J, Engles JM, Yu J, Leppo MK, Pomper MG, Wahl RL, Seidel J, Tsui BM, Bengel FM, Abraham MR, Marban E (2009) Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54: 1619-1626.
61. Thelin MA, Bartolini B, Axelsson J, Gustafsson R, Tykesson E, Pera E, Oldberg A, Maccarana M, Malmstrom A (2013) Biological functions of iduronic acid in chondroitin/dermatan sulphate. FEBS J 280: 2431-2446.
62. Toida T, Shima M, Azumaya S, Maruyama T, Toyoda H, Imanari T, Linhardt RJ (1997) Detection of glycosaminoglycans as a copper(II) complex in high-performance liquid chromatography. J Chromatogr A 787: 266-270.
63. Toyoda H, Yamamoto H, Ogino N, Toida T, Imanari T (1999) Rapid and sensitive analysis of disaccharide composition in heparin and heparan sulphate by reversed-phase ion-pair chromatography on a 2 μm porous silica gel column J Chromatogr A 830: 197-201.
64. Tran TH, Shi X, Zaia J, Ai X (2012) Heparan sulphate 6-O-endosulfatases (Sulfs) coordinate the Wnt signaling pathways to regulate myoblast fusion during skeletal muscle regeneration. J Biol Chem 287: 32651-32664.
65. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109: 2058-2067.
66. Villena J, Brandan E (2004) Dermatan sulphate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration. J Cell Physiol 198: 169-178.
67. Wang L, Fuster M, Sriramarao P, Esko JD (2005) Endothelial heparan sulphate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6: 902-910.
68. Yablonka-Reuveni Z, Seger R, Rivera AJ (1999) Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem 47: 23-42.
69. Yamagata T, Saito H, Habuchi O, Suzuki S (1968) Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 243: 1523-1535.
70. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischaemic neovascularization. Circulation 107: 1322-1328.
71. Yamauchi H, Desgranges P, Lecerf L, Papy-Garcia D, Tournaire MC, Moczar M, Loisance D, Barritault D (2000) New agents for the treatment of infarcted myocardium. FASEB J 14: 2133-2134.
72. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J (2007) Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115: 1866-1875.